XENTINEL

Welcome to the Brand page for “XENTINEL”, which is offered here for Medical and scientific research services, providing genome information that provides patients with personalized drug reaction risk information; medical computer software diagnostics development platform featuring temporary use of online non-downloadable software and featuring temporary use of online non-downloadable diagnostics software tools for identification and diagnosis of individuals at risk for adverse drug reactions; temporary use of online non-downloadable software for genome and whole exome-based drug discovery featuring drug repositioning and drug-gene interactions; providing temporary use of online non-downloadable software that facilitates development of molecular diagnostic tools for personalized drug choice for patients and healthcare providers; testing, analysis and evaluation of genetic causes of adverse drug reactions in patients;.

Its status is currently believed to be active. Its class is unavailable. “XENTINEL” is believed to be currently owned by “Cipherome, Inc.”